Table 4 Logistic regression analysis of risk factors affecting the incidence of ICIs-related myocarditis
From: Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
Factors | Univariable | Â | Multivariable | ||
|---|---|---|---|---|---|
Hazard Ratio (95% CI) | P Value |  | Hazard Ratio (95% CI) | P Value | |
Age ≥ 70 | 0.4(0.19–0.89) | 0.025 |  | 0.4(0.16–0.84) | 0.018 |
BMI ≥ 24 | 1.0(0.48–1.86) | 0.808 |  |  |  |
Male | 0.4(0.14–0.97) | 0.044 |  | 0.5(0.16–1.53) | 0.225 |
Smoke | 0.6(0.25–1.35) | 0.204 |  |  |  |
NSCLC | 0.4(0.16–0.85) | 0.019 |  |  |  |
IV stage | 1.3(0.57–3.10) | 0.518 |  |  |  |
PD1 | 0.3(0.13–0.89) | 0.028 |  | 0.4(0.13–0.97) | 0.043 |
Combined ICI | 1.5(0.68–4.27) | 0.369 |  |  |  |
Cardiovascular history | 1.2(0.64–2.53) | 0.601 |  |  |  |
Diabetes Mellitus | 0.8(0.33–2.34) | 0.628 |  |  |  |